Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study

3 years ago

Media Release Appointment of Charles River Laboratories ("Charles River") to run Immutep’s preclinical toxicology study evaluating the safety and toxicity…

Le Bal Rouge Gala raises $1.68M for MUHC Foundation Dream Big: Breathe Easier Campaign

3 years ago

With the Glitz and Glamour of a 20s Speakeasy, the Gala Honoured the Achievements of Dr. Kevin Schwartzman and the…

Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business

3 years ago

Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business…

StateHouse to Report First Quarter 2023 Financial Results on May 31st, 2023

3 years ago

SAN DIEGO and TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQX:…

Mithra Appoints Experienced Life Sciences Executive Christian Homsy* as Chairman

3 years ago

Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit CommitteeLiege, Belgium, 29 May…

BioSenic provides update regarding current license agreement with Phebra

3 years ago

INSIDE INFORMATION Maintenance of the license is now subject to the launch of the OATO Phase III before May 2024…

PwC and Claritas HealthTech Enter into Strategic Relationship for the Deployment of Claritas’ Medical Imaging Platforms

3 years ago

SINGAPORE and LONDON, May 28, 2023 (GLOBE NEWSWIRE) -- Claritas HealthTech and PwC today announced that they will collaborate on…

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

3 years ago

Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023 First Potential Approval of an…

Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

3 years ago

AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company…

Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering

3 years ago

26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering               Biodexa Pharmaceuticals PLC (“Biodexa” or…